Inflammatory bowel disease (IBD), the collective term for a group of chronic conditions characterised by inflammation of the gastrointestinal tract (including Crohn’s disease and ulcerative colitis), affects an estimated 1.4 million individuals in the US, and its incidence is increasing worldwide. Current treatments generally manage the symptoms rather than provide a cure, highlighting the need to develop effective molecular therapies. In this new study, Nathan Bahary and colleagues use zebrafish to demonstrate that a deficiency in phosphatidylinositol (PI) signalling could be involved in the pathogenesis of IBD. Abnormalities in PI signalling have been linked with gastrointestinal disorders; however, the mechanisms remained unclear. Here, the authors show that PI-synthesis-deficient zebrafish display persistent ER stress and disrupted intestinal architecture, resulting in IBD-like pathologies. These effects can be mimicked by pharmacological induction of ER stress, whereas abrogation of ER stress using chemical chaperones rescues the disease phenotype. These findings link PI signalling defects with ER-stress-mediated gastrointestinal disease, revealing a mechanism that could be targeted in the development of curative therapies for IBD. Page 93
Phosphatidylinositol signalling defects implicated in IBD
Phosphatidylinositol signalling defects implicated in IBD. Dis Model Mech 1 January 2014; 7 (1): 1. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2024: Pre-clinical Modelling of Human Genetic Disease and Therapy

Registration is open for our 2024 Journal Meeting. Rapid advances in gene editing and genetic technologies have revolutionised our ability to model human genetic disease and provided new hope for gene therapies. At this Meeting, speakers will present the very latest advances in modelling human genetic disease.
Moving towards heart success – Disease Models & Mechanisms Special Issue

DMM's most recent special issue compiles articles that investigate the genetic and biological mechanisms of heart failure and identify potential therapeutic strategies.
Sustainable Conferencing Initiative

Through our Sustainable Conferencing Grants, we promote the use of new technology and greener modes of travel. Our blog posts showcase examples of sustainability in action and share guidance about how new technologies and different conference formats work in practice.
Other journals from
The Company of Biologists